Filtered By:
Condition: Hemorrhagic Stroke
Countries: Switzerland Health
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 54 results found since Jan 2013.
Successful weaning versus permanent cerebrospinal fluid diversion after aneurysmal subarachnoid hemorrhage: post hoc analysis of a Swiss multicenter study
CONCLUSIONS: These results show a temporary but clinically meaningful cognitive benefit in the first weeks after aSAH in successfully weaned patients. The resolution of this difference over time may be due to the positive effects of permanent CSF diversion and underlines its importance. Patients who do not show progressive neuropsychological improvement after weaning should be considered for repeat CT imaging to rule out chronic (untreated) hydrocephalus.PMID:37004134 | DOI:10.3171/2023.1.FOCUS22638
Source: Neurosurgical Focus - April 2, 2023 Category: Neurosurgery Authors: Ahmed El-Garci Olivia Zindel-Geisseler Noemi Dannecker Yannick Rothacher Ladina Schlosser Anna Zeitlberger Julia Velz Martina Seb ök Noemi Eggenberger Adrien May Philippe Bijlenga Ursula Guerra-Lopez Rodolfo Maduri Val érie Beaud Daniele Starnoni Alessi Source Type: research
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Media News - July 24, 2023 Category: Pharmaceuticals Source Type: news
